glp-1 agonist adverse effects Receptor Agonists Clinical Focus on GLP-1 Agonists

The GLP-1 analogues market is growing rapidly due to the increasing incidence of diabetes and obesity in the world, which is fueling a high demand for treatments that can efficiently control body weight and blood sugar

doi: 10.1211/jpp.61.01.0008

Another study, the EXAMINE trial, investigated alogliptin medication in individuals with Type 2 diabetes who had experienced acute coronary syndrome and revealed no increase in major adverse cardiovascular events

Dispelling common myths about these treatments can help set more realistic expectations

The focus is on dietary changes , physical activity, and oral medication

The prevalence of polycystic ovary syndrome in reproductive-aged women of different ethnicity: a systematic review and meta-analysis